Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stylianos Tomaras

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Innere Medizin (Heidelberg, Germany)|January 27, 2023
[Myositis]Stylianos Tomaras, Eugen Feist
Journal of Clinical Medicine|May 28, 2022
Curcumin: Useful add-on for Rheumatic Diseases?Stylianos Tomaras, Gernot Keyßer, Eugen Feist
Deutsche Medizinische Wochenschrift (1946)|July 3, 2020
[Idiopathic Inflammatory Myopathies]Stylianos Tomaras, Jörn Kekow, Eugen Feist
Therapeutic Advances in Musculoskeletal Disease|December 6, 2021
Update on the therapy of adult-onset Still's disease with a focus on IL-1-inhibition: a systematic reviewClaudia Kedor, Stylianos Tomaras, Daniel Baeumer, et al.
Journal of Clinical Medicine|March 6, 2021
Adult-Onset Still's Disease: Clinical Aspects and Therapeutic ApproachStylianos Tomaras, Carl Christoph Goetzke, Tilmann Kallinich, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 6, 2021
Quantification of the janus kinase 1 inhibitor upadacitinib in human plasma by LC-MS/MSJens Martens-Lobenhoffer, Stylianos Tomaras, Eugen Feist, et al.
Cells|October 23, 2021
NK Cell Patterns in Idiopathic Inflammatory Myopathies with Pulmonary AffectionMarc Pawlitzki, Christopher Nelke, Leoni Rolfes, et al.
Acta Neuropathologica|May 25, 2022
Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositisCorinna Preuße, Barbara Paesler, Christopher Nelke, et al.
Rheumatology (Oxford, England)|October 25, 2022
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD studyMrinalini Dey, Naveen R, Elena Nikiphorou, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Innere Medizin (Heidelberg, Germany)|January 27, 2023
[Myositis]Stylianos Tomaras, Eugen Feist
Journal of Clinical Medicine|May 28, 2022
Curcumin: Useful add-on for Rheumatic Diseases?Stylianos Tomaras, Gernot Keyßer, Eugen Feist
Deutsche Medizinische Wochenschrift (1946)|July 3, 2020
[Idiopathic Inflammatory Myopathies]Stylianos Tomaras, Jörn Kekow, Eugen Feist
Therapeutic Advances in Musculoskeletal Disease|December 6, 2021
Update on the therapy of adult-onset Still's disease with a focus on IL-1-inhibition: a systematic reviewClaudia Kedor, Stylianos Tomaras, Daniel Baeumer, et al.
Journal of Clinical Medicine|March 6, 2021
Adult-Onset Still's Disease: Clinical Aspects and Therapeutic ApproachStylianos Tomaras, Carl Christoph Goetzke, Tilmann Kallinich, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 6, 2021
Quantification of the janus kinase 1 inhibitor upadacitinib in human plasma by LC-MS/MSJens Martens-Lobenhoffer, Stylianos Tomaras, Eugen Feist, et al.
Cells|October 23, 2021
NK Cell Patterns in Idiopathic Inflammatory Myopathies with Pulmonary AffectionMarc Pawlitzki, Christopher Nelke, Leoni Rolfes, et al.
Acta Neuropathologica|May 25, 2022
Skeletal muscle provides the immunological micro-milieu for specific plasma cells in anti-synthetase syndrome-associated myositisCorinna Preuße, Barbara Paesler, Christopher Nelke, et al.
Rheumatology (Oxford, England)|October 25, 2022
Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD studyMrinalini Dey, Naveen R, Elena Nikiphorou, et al.
Pageof 1